Radiolabeled nanomaterials for biomedical applications: radiopharmacy in the era of nanotechnology

EJNMMI Radiopharmacy and Chemistry(2022)

引用 26|浏览11
暂无评分
摘要
Background Recent advances in nanotechnology have offered new hope for cancer detection, prevention, and treatment. Nanomedicine, a term for the application of nanotechnology in medical and health fields, uses nanoparticles for several applications such as imaging, diagnostic, targeted cancer therapy, drug and gene delivery, tissue engineering, and theranostics. Results Here, we overview the current state-of-the-art of radiolabeled nanoparticles for molecular imaging and radionuclide therapy. Nanostructured radiopharmaceuticals of technetium-99m, copper-64, lutetium-177, and radium-223 are discussed within the scope of this review article. Conclusion Nanoradiopharmaceuticals may lead to better development of theranostics inspired by ingenious delivery and imaging systems. Cancer nano-theranostics have the potential to lead the way to more specific and individualized cancer treatment. Graphical abstract
更多
查看译文
关键词
Radiolabeled nanoparticles,Technetium-99m,Copper-64,Lutetium-177,Radium-223,Molecular imaging,Radionuclide therapy,Theranostics,Toxicity,Radiopharmacy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要